Floatz logo

Therapeutic Asset Ratings

3,227 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Calcium
Epilepsy
The Fourth Affiliated Hospital of Zhejiang University School of MedicineP4B (58)
Candesartan
Tinnitus
Stanford UniversityP4B (58)
Capmatinib
Non-Small Cell Lung Carcinoma
Sun Yat-sen UniversityP4B (58)
Carvedilol
Portal Vein Thrombosis
Asian Institute Of Medical SciencesP4B (58)
Cefadroxil Anhydrous
Autoimmune Disease
Mayo ClinicP4B (58)
Cefadroxil Anhydrous
Diabetes Mellitus
Mayo ClinicP4B (58)
Cefadroxil Anhydrous
Obesity Disorder
Mayo ClinicP4B (58)
Ceftazidime
Acute Myeloid Leukemia
Gadjah Mada UniversityP4B (58)
Celecoxib
Major Depressive Disorder
Stony Brook UniversityP4B (58)
Cephalexin
Autoimmune Disease
Mayo ClinicP4B (58)
Cephalexin
Diabetes Mellitus
Mayo ClinicP4B (58)
Cephalexin
Obesity Disorder
Mayo ClinicP4B (58)
Cerebrolysin
Type 2 Diabetes Mellitus
Hospital Universitario Dr. Jose E. GonzalezP4B (58)
Cerebrolysin
Intracerebral Hemorrhage
Cardinal Stefan Wyszynski UniversityP4B (58)
Cetirizine
Multiple Sclerosis
University of MiamiP4B (58)
Ciprofloxacin
Neutropenia
Hospital Universitari Vall d'Hebron Research InstituteP4B (58)
Citalopram
Stroke Disorder
Chih-Wei TangP4B (58)
Clonazepam
Bipolar Disorder
Dr. Stavroula RakitziP4B (58)
Clostridium Butyricum
Chemotherapy-Induced Toxicity
The Affiliated Hospital of Qingdao UniversityP4B (58)
Cogentin
Schizoaffective Disorder
University of PittsburghP4B (58)
Compound Kushen Injection
Colorectal Carcinoma
Guang'anmen Hospital of China Academy of Chinese Medical SciencesP4B (58)
Copper Cu 64-Dota-Trastuzumab
Breast Cancer
City of Hope Medical CenterP4B (58)
Copper Cu 64-Dota-Trastuzumab
Breast Carcinoma
City of Hope Medical CenterP4B (58)
Dabrafenib
Anaplastic Astrocytoma
National Cancer Institute (NCI)P4B (58)
Dabrafenib
Malignant Glioma
National Cancer Institute (NCI)P4B (58)
Showing 2676 to 2700 of 3,227 assets
PreviousPage 108 of 130Next